Grp94 modulated intracellular trafficking of HER2 and promoted its stabilization at the plasma-cell membrane in tumor cells, so its overexpression has been implicated in HER2+ BC pathogenesis [100]. This evidence concerns the gene ERBB2 and breast cancer.